Cysteine-Directed Isobaric Labeling Combined with GeLC-FAIMS-MS for Quantitative Top-Down Proteomics
Journal of Proteome Research · 07.03.2025 · 24 (3) · 1470-1480
DOI: 10.1021/acs.jproteome.4c00835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 31.01.2025. Verfasst von Theo Matzanke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Systematic Proteome Research & Bioanalytics, Institute for Experimental Medicine, Christian-Albrechts-Universität zu Kiel, 24105 Kiel, Germany. Hauptthemen laut MEDLINE: Cysteine, Proteomics, Proteome, Escherichia coli Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, RTF-V.
Abstract (Originalsprache)
High Resolution Image Download MS PowerPoint Slide The quantification of proteoforms, i.e., all molecular forms in which proteins can be present, by top-down proteomics provides essential insights into biological processes at the molecular level. Isobaric labeling-based quantification strategies are suitable for multidimensional separation strategies and allow for multiplexing of the samples. Here, we investigated cysteine-directed isobaric labeling by iodoTMT in combination with a gel- and gas-phase fractionation (GeLC-FAIMS-MS) for in-depth quantitative proteoform analysis. We optimized the acquisition workflow (i.e., the FAIMS compensation voltages, isolation windows, acquisition strategy, and fragmentation method) using a two-proteome mix to increase the number of quantified proteoforms and reduce ratio compression. Additionally, we implemented a mass feature-based quantification strategy in the widely used deconvolution algorithm FLASHDeconv, which improves and facilitates data analysis. The optimized iodoTMT GeLC-FAIMS-MS workflow was applied to quantitatively analyze the proteome of Escherichia coli grown under glucose or acetate as the sole carbon source, resulting in the identification of 726 differentially abundant proteoforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Systematic Proteome Research & Bioanalytics, Institute for Experimental Medicine, Christian-Albrechts-Universität zu Kiel, 24105 Kiel, Germany.
- Applied Bioinformatics, Computer Science Department, University of Tübingen, Sand 14, 72076 Tübingen, Germany.
- Institute for Bioinformatics and Medical Informatics, University of Tübingen, Sand 14, 72076 Tübingen, Germany.
- Advanced Research Support Center, Institute for Promotion of Science and Technology, Ehime University, Toon 791-0295, Japan.
- Translational Bioinformatics, University Hospital Tübingen, Hoppe-Seyler-Str. 9, 72076 Tübingen, Germany.
ORCID-Profile: Philipp T Kaulich, Kyowon Jeong, Ayako Takemori, Nobuaki Takemori, Oliver Kohlbacher, Andreas Tholey
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- RTF-V
Zitieren
APA
Matzanke, T., Kaulich, P. T., Jeong, K., Takemori, A., Takemori, N., Kohlbacher, O., & Tholey, A. (2025). Cysteine-Directed Isobaric Labeling Combined with GeLC-FAIMS-MS for Quantitative Top-Down Proteomics. Journal of Proteome Research, 24(3), 1470-1480. https://doi.org/10.1021/acs.jproteome.4c00835
Vancouver
Matzanke T, Kaulich PT, Jeong K, Takemori A, Takemori N, Kohlbacher O, et al. Cysteine-Directed Isobaric Labeling Combined with GeLC-FAIMS-MS for Quantitative Top-Down Proteomics. Journal of Proteome Research. 2025;24(3):1470-1480. doi:10.1021/acs.jproteome.4c00835
BibTeX
@article{Matzanke2025,
author = {Matzanke, Theo and Kaulich, Philipp T and Jeong, Kyowon and Takemori, Ayako and Takemori, Nobuaki and Kohlbacher, Oliver and Tholey, Andreas},
title = {Cysteine-Directed Isobaric Labeling Combined with GeLC-FAIMS-MS for Quantitative Top-Down Proteomics},
journal = {Journal of Proteome Research},
year = {2025},
volume = {24},
number = {3},
pages = {1470--1480},
doi = {10.1021/acs.jproteome.4c00835}
}
EUVIMED